ISTOCK,OCSKAYMARK
Two Experimental Drugs Reduce Infections in the Elderly
Two Experimental Drugs Reduce Infections in the Elderly
Despite the treatment being given for only six weeks, the positive effects lasted for a year.
Two Experimental Drugs Reduce Infections in the Elderly
Two Experimental Drugs Reduce Infections in the Elderly

Despite the treatment being given for only six weeks, the positive effects lasted for a year.

Despite the treatment being given for only six weeks, the positive effects lasted for a year.

combination therapy
Immune Therapy Improves Lung Cancer Patients’ Survival
Immune Therapy Improves Lung Cancer Patients’ Survival
Jim Daley | Apr 17, 2018
Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
FDA Approves Clinical Trials to Test Cuban Cancer Vaccine
FDA Approves Clinical Trials to Test Cuban Cancer Vaccine
Bob Grant | Oct 31, 2016
An early-stage study of the effectiveness of a lung-cancer vaccine developed by scientists in Cuba could start as early as next month.
Chemotherapy Pioneer Dies
Chemotherapy Pioneer Dies
Dan Cossins | May 6, 2013
Emil Frei III, a cancer researcher who in the 1950s combined multiple chemotherapy drugs to treat childhood leukemia, has died at the age of 89.
Tuberculosis Trial Launched
Hannah Waters | Mar 20, 2012
The TB Alliance will test a new combination of drugs to combat normal and multi-drug-resistant tuberculosis.